N,N-Dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

Catalog No. :
ACWKDG968
CAS No. :
1310385-02-4
Molecular Formula :
C13H21BN2O2
Molecular Weight :
248.13

IUPAC Name:N,N-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

N,N-Dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$1199.00Login to see priceInquiryInquiry
1g95%$1559.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,N-Dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
IUPAC NameN,N-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
MDL No.MFCD09879113
Molecular FormulaC13H21BN2O2
Molecular Weight248.13
SMILESCC1(C)C(C)(C)OB(C2=CC=CC(N(C)C)=N2)O1
InChI KeyQVOVJYWZHFIBHU-UHFFFAOYSA-N
Synonym6-DIMETHYLAMINOPYRIDINE-2-BORONIC ACID PINACOL ESTER;2-Pyridinamine, N,N-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1310385-02-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWKDG968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKBW320 route compound structure diagram
    ACNKBW320112575-13-0 In Stock
  2. Then
  3. ACWKDG968 route product structure diagram
    ACWKDG9681310385-02-4
Inquiry

2. ACWKDG968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACNKBW320 route compound structure diagram
    ACNKBW320112575-13-0 In Stock
  4. Then
  5. ACWKDG968 route product structure diagram
    ACWKDG9681310385-02-4
Inquiry

Comments (0)